Navigation Links
Prostate Cancer Added to List of Diseases Eligible for Zadroga Act Coverage; Parker Waichman LLP Applauds Decision
Date:9/20/2013

New York, New York (PRWEB) September 20, 2013

Parker Waichman LLP, a national law firm that has spent the past decade working to ensure that the heroes of 9/11 are not forgotten, applauds the fact that prostate cancer has been added to the list of cancers covered by the Zadroga 9/11 law. This decision comes about three weeks before the registration deadline for the September 11th Victim Compensation Fund, as reported by the U.S. Department of Health and Human Services on Sept. 19. It noted that, back in September 2012, the National Institute for Occupational Safety and Health (NIOS) had added about 50 cancers to the list of diseases covered under the James Zadroga 9/11 Health and Compensation Act of 2010. Prostate cancer was noticeably missing from the list. Then in May 2013, the New York City Patrolmen's Benevolent Association filed a petition to add the cancer. NIOSH published a proposed rule to add the cancer in July; the final rule, which added prostate cancer, was posted on the Federal Register on Sept. 19.

The Zadroga Act, which became law in December 2010, was named for deceased New York Police Department detective James Zadroga, who had worked at Ground Zero, as noted in Public Law 111, issued on Jan. 2, 2011. Many of the individuals who participated in the rescue and recovery efforts following the 9/11 terrorist attacks have since been diagnosed with various illnesses because of their exposure to toxic dust, as reported by The Lancet on Sept. 3, 2011. The Zadroga Act reopened the 9/11 Victims Compensation Fund for five years to provide payment for job and economic losses for first responders, those trapped in the buildings, and local residents, who suffered illnesses or injuries related to the toxic dust, the U.S. Department of Justice noted in a press release at the time.

“We knew it was only a matter of time before this day would come, when prostate cancer would be added to the list of cancers covered under the Zadroga Act,” said Matthew J. McCauley, who is the leading attorney in the WTC/Zadroga group at Parker Waichman LLP and a former NYPD Officer and WTC First Responder. “We continue to honor our 9/11 Heroes and will forever stand by them and their families for the ultimate sacrifices they have made.”

Parker Waichman LLP worked alongside Ground Zero first responders and their advocates to ensure passage of the Zadroga Act. The firm vows to continue its efforts to make sure these heroes receive all of the Zadroga Act compensation they need and deserve.

If you or a loved one are eligible for compensation under the Zadroga Act, and would like assistance with your claim, please visit Parker Waichman LLP's Zadroga Act claims page at yourlawyer.com or call 1-800-LAW-INFO (1-800-529-4636).

Contact:
Parker Waichman LLP
Gary Falkowitz, Managing Attorney
1+(800) LAW-INFO
1+(800) 529-4636
http://www.yourlawyer.com

Read the full story at http://www.prweb.com/releases/zadroga_prostate_addition/09/prweb11146704.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Moffitt Cancer Center launches prostate cancer study focused on black men
2. Made Sick from Prostate Cancer Awareness and Screening
3. LUGPA: Ladies: Save That Special Man in Your Life by Encouraging a Prostate Test in September
4. CEO of Award-Winning SEO Services Company, 180Fusion, Scott Cohen Elected to Emcee 2013 Prostate Cancer Dinner Gala
5. Cleveland Clinic researcher finds genetic mutation in castration-resistant prostate cancer
6. Targeting aggressive prostate cancer
7. Prostate cancer screening: New data support watchful waiting
8. UCLA prostate cancer research program receives $11.6 million federal grant
9. A Blast from the Past: a Prostate Cancer Fundraiser at the Hamptons
10. North Shore-LIJ Offering New Radium Treatment for Prostate Cancer Patients
11. Decision aids associated with increase in informed decision making about prostate cancer screening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history of ... Brink” is the creation of published author, William Nowers. Captain Nowers and his ... veteran, he spent thirty years in the Navy. Following his career as a ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
(Date:10/12/2017)... ... 2017 , ... The company has developed a suite of ... authorities worldwide. From Children’s to Adults 50+, every formula has been developed by ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, Preservative ...
(Date:10/12/2017)... ... ... The American College of Medical Informatics (ACMI) will present the 2017 Morris ... of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is taking ... in the field of medical informatics, this prestigious award is presented to an individual ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., a ... design, and immune-engineering today announced the launch of ... development of personalized therapeutic cancer vaccines. EpiVax has ... exclusive access to enabling technologies to the new ... will lead EpiVax Oncology as Chief Executive Officer. ...
(Date:9/22/2017)... -- As the latest Obamacare repeal effort moves is debated, ... and Lindsey Graham (R-SC) medical device market ... is in an odd place.  The industry wants repeal ... on medical device sales passed along with the Affordable ... visits and hospital customers with the funding to invest ...
(Date:9/19/2017)... a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses pulsed ...   ... Jim Bertolina, ... Tom Tefft ... medical device executive Josh Stopek , PhD, who has led R&D and business development ...
Breaking Medicine Technology: